Showing results (21-30 of 107) with videos related to
Sort By:
Pageof 11
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 7, 2026
Acid sphingomyelinase is an age-dependent host cell factor for adenovirus entry and a pharmacological target for synergistic combination therapy with brincidofovirSophie Post, Mohamed Zamzamy, Luca Benthien, et al.British Journal of Pharmacology|November 28, 2025
Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovirMohamed Zamzamy, Sophie Post, Wing Hang Ip, et al.Cell Cycle (Georgetown, Tex.)|May 8, 2008
The adenovirus E1B-55K oncoprotein induces SUMO modification of p53Stefan Muller, Thomas DobnerMethods in Molecular Medicine|July 28, 2007
Determination of the transforming activities of adenovirus oncogenesMichael Nevels, Thomas DobnerJournal of Virology|October 20, 2006
Adenovirus type 5 early region 1B 156R protein promotes cell transformation independently of repression of p53-stimulated transcriptionTimo Sieber, Thomas DobnerMethods in Molecular Medicine|April 3, 2007
Construction of adenovirus type 5 early region 1 and 4 virus mutantsPeter Groitl, Thomas DobnerJournal of Virology|March 7, 2009
Arginine methylation of human adenovirus type 5 L4 100-kilodalton protein is required for efficient virus productionOrkide O Koyuncu, Thomas DobnerViruses|February 28, 2023
Updates and New Perspectives on Adenoviral Gene Therapy and Vaccine VectorsThomas Dobner, Luca D BertzbachJournal of Virology|November 11, 2011
Human pathogens and the host cell SUMOylation systemPeter Wimmer, Sabrina Schreiner, Thomas DobnerJournal of Virology|December 23, 2011
The human adenovirus type 5 E1B 55-kilodalton protein is phosphorylated by protein kinase CK2Wilhelm Ching, Thomas Dobner, Emre KoyuncuPageof 11